Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin
- 1 November 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (5) , 1910-1916
- https://doi.org/10.1046/j.1523-1755.2001.00028.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient miceJournal of Clinical Investigation, 2000
- Ace inhibitors and erythropoietin response in hemodialysis patients.American Journal of Kidney Diseases, 2000
- Angiotensin II stimulates proliferation of normal early erythroid progenitors.Journal of Clinical Investigation, 1997
- Angiotensin Converting Enzyme Inhibitors Are Associated with the Need for Increased Recombinant Human Erythropoietin Maintenance Doses in Hemodialysis PatientsNephron, 1997
- Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?American Journal of Kidney Diseases, 1996
- Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?Nephrology Dialysis Transplantation, 1996
- Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.Journal of Clinical Investigation, 1996
- The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting EnzymeJournal of Biological Chemistry, 1995
- Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.Proceedings of the National Academy of Sciences, 1989
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983